Titre : Axe hypothalamohypophysaire

Axe hypothalamohypophysaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gene Expression Regulation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Axe hypothalamohypophysaire : Questions médicales les plus fréquentes", "headline": "Axe hypothalamohypophysaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Axe hypothalamohypophysaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-14", "dateModified": "2025-04-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Axe hypothalamohypophysaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Système neuroendocrinien", "url": "https://questionsmedicales.fr/mesh/D009490", "about": { "@type": "MedicalCondition", "name": "Système neuroendocrinien", "code": { "@type": "MedicalCode", "code": "D009490", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.713" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Axe hypothalamo-hypophyso-gonadique", "alternateName": "Hypothalamic-Pituitary-Gonadal Axis", "url": "https://questionsmedicales.fr/mesh/D000094365", "about": { "@type": "MedicalCondition", "name": "Axe hypothalamo-hypophyso-gonadique", "code": { "@type": "MedicalCode", "code": "D000094365", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.713.357.250" } } }, { "@type": "MedicalWebPage", "name": "Éminence médiane", "alternateName": "Median Eminence", "url": "https://questionsmedicales.fr/mesh/D008473", "about": { "@type": "MedicalCondition", "name": "Éminence médiane", "code": { "@type": "MedicalCode", "code": "D008473", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.713.357.500" } } }, { "@type": "MedicalWebPage", "name": "Hypophyse", "alternateName": "Pituitary Gland", "url": "https://questionsmedicales.fr/mesh/D010902", "about": { "@type": "MedicalCondition", "name": "Hypophyse", "code": { "@type": "MedicalCode", "code": "D010902", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.713.357.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adénohypophyse", "alternateName": "Pituitary Gland, Anterior", "url": "https://questionsmedicales.fr/mesh/D010903", "about": { "@type": "MedicalCondition", "name": "Adénohypophyse", "code": { "@type": "MedicalCode", "code": "D010903", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.713.357.750.500" } } }, { "@type": "MedicalWebPage", "name": "Hypophyse intermédiaire", "alternateName": "Pituitary Gland, Intermediate", "url": "https://questionsmedicales.fr/mesh/D052716", "about": { "@type": "MedicalCondition", "name": "Hypophyse intermédiaire", "code": { "@type": "MedicalCode", "code": "D052716", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.713.357.750.750" } } }, { "@type": "MedicalWebPage", "name": "Neurohypophyse", "alternateName": "Pituitary Gland, Posterior", "url": "https://questionsmedicales.fr/mesh/D010904", "about": { "@type": "MedicalCondition", "name": "Neurohypophyse", "code": { "@type": "MedicalCode", "code": "D010904", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.713.357.750.875" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Axe hypothalamohypophysaire", "alternateName": "Hypothalamo-Hypophyseal System", "code": { "@type": "MedicalCode", "code": "D007030", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sabrina Chiloiro", "url": "https://questionsmedicales.fr/author/Sabrina%20Chiloiro", "affiliation": { "@type": "Organization", "name": "Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy." } }, { "@type": "Person", "name": "Laura De Marinis", "url": "https://questionsmedicales.fr/author/Laura%20De%20Marinis", "affiliation": { "@type": "Organization", "name": "Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address: Laura.DeMarinis@unicatt.it." } }, { "@type": "Person", "name": "Tommaso Tartaglione", "url": "https://questionsmedicales.fr/author/Tommaso%20Tartaglione", "affiliation": { "@type": "Organization", "name": "Department of Radiology, Istituto Dermopatico dell'Immacolata, Rome and Università Cattolica del Sacro Cuore, Rome, Italy." } }, { "@type": "Person", "name": "Antonella Giampietro", "url": "https://questionsmedicales.fr/author/Antonella%20Giampietro", "affiliation": { "@type": "Organization", "name": "Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy." } }, { "@type": "Person", "name": "Antonio Bianchi", "url": "https://questionsmedicales.fr/author/Antonio%20Bianchi", "affiliation": { "@type": "Organization", "name": "Pituitary Unit, Department of Endocrinology, Fondazione A Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Insulin promotes the proliferation and migration of pancreatic cancer cells by up-regulating the expression of PLK1 through the PI3K/AKT pathway.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36724556", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bbrc.2023.01.061" } }, { "@type": "ScholarlyArticle", "name": "Salicylic acid delays pear fruit senescence by playing an antagonistic role toward ethylene, auxin, and glucose in regulating the expression of", "datePublished": "2023-01-11", "url": "https://questionsmedicales.fr/article/36714736", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpls.2022.1096645" } }, { "@type": "ScholarlyArticle", "name": "Epstein-Barr Virus Regulates Endothelin-1 Expression through the ERK/FOXO1 Pathway in EBV-Associated Gastric Cancer.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36475746", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/spectrum.00898-22" } }, { "@type": "ScholarlyArticle", "name": "Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity.", "datePublished": "2022-11-17", "url": "https://questionsmedicales.fr/article/36394642", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00262-022-03327-w" } }, { "@type": "ScholarlyArticle", "name": "Proliferation, Metastasis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells in the Expression and Effect of Kiwifruit Extract through the Regulation of miR-205-5p.", "datePublished": "2022-08-11", "url": "https://questionsmedicales.fr/article/35990993", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/6925772" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système nerveux", "item": "https://questionsmedicales.fr/mesh/D009420" }, { "@type": "ListItem", "position": 3, "name": "Système neuroendocrinien", "item": "https://questionsmedicales.fr/mesh/D009490" }, { "@type": "ListItem", "position": 4, "name": "Axe hypothalamohypophysaire", "item": "https://questionsmedicales.fr/mesh/D007030" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Axe hypothalamohypophysaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Axe hypothalamohypophysaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Axe hypothalamohypophysaire", "description": "Comment diagnostiquer un dysfonctionnement de l'axe ?\nQuels tests hormonaux sont utilisés ?\nQuels symptômes indiquent un problème hypothalamique ?\nQuand consulter un endocrinologue ?\nL'imagerie est-elle nécessaire pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Gene+Expression+Regulation&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Axe hypothalamohypophysaire", "description": "Quels sont les symptômes d'un excès de prolactine ?\nComment se manifeste un déficit en cortisol ?\nQuels signes indiquent un hyperthyroïdisme ?\nQuels symptômes sont liés à l'hypopituitarisme ?\nComment reconnaître un syndrome de Cushing ?", "url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Gene+Expression+Regulation&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Axe hypothalamohypophysaire", "description": "Peut-on prévenir les troubles hormonaux ?\nComment éviter le stress sur l'axe hypothalamique ?\nLes examens réguliers sont-ils importants ?\nL'exercice physique aide-t-il l'axe hormonal ?\nFaut-il surveiller les antécédents familiaux ?", "url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Gene+Expression+Regulation&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Axe hypothalamohypophysaire", "description": "Quels traitements pour l'hyperprolactinémie ?\nComment traiter un déficit en hormone de croissance ?\nQuelles options pour l'hypothyroïdie ?\nComment gérer le syndrome de Cushing ?\nQuels médicaments pour l'hypopituitarisme ?", "url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Gene+Expression+Regulation&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Axe hypothalamohypophysaire", "description": "Quelles complications peuvent survenir avec l'hypopituitarisme ?\nQuels risques avec un excès de cortisol ?\nComment l'hyperthyroïdie affecte-t-elle le cœur ?\nQuelles sont les conséquences d'un traitement inapproprié ?\nQuels effets secondaires des médicaments hormonaux ?", "url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Gene+Expression+Regulation&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Axe hypothalamohypophysaire", "description": "Quels facteurs augmentent le risque d'hypopituitarisme ?\nLe stress est-il un facteur de risque ?\nL'âge influence-t-il les troubles hormonaux ?\nLes maladies auto-immunes sont-elles un risque ?\nY a-t-il un lien avec l'obésité ?", "url": "https://questionsmedicales.fr/mesh/D007030?mesh_terms=Gene+Expression+Regulation&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un dysfonctionnement de l'axe ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests hormonaux et des IRM peuvent aider à diagnostiquer les troubles." } }, { "@type": "Question", "name": "Quels tests hormonaux sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les dosages de cortisol, TSH et prolactine sont couramment utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème hypothalamique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la température, de l'appétit ou des cycles menstruels peuvent indiquer un problème." } }, { "@type": "Question", "name": "Quand consulter un endocrinologue ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Si des symptômes hormonaux persistants apparaissent, une consultation est recommandée." } }, { "@type": "Question", "name": "L'imagerie est-elle nécessaire pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'IRM peut révéler des anomalies structurelles de l'hypophyse." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un excès de prolactine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent galactorrhée, irrégularités menstruelles et infertilité." } }, { "@type": "Question", "name": "Comment se manifeste un déficit en cortisol ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Il se manifeste par fatigue, perte de poids, et hypotension." } }, { "@type": "Question", "name": "Quels signes indiquent un hyperthyroïdisme ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Perte de poids, nervosité, et palpitations sont des signes d'hyperthyroïdisme." } }, { "@type": "Question", "name": "Quels symptômes sont liés à l'hypopituitarisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, perte de libido et troubles de croissance peuvent indiquer l'hypopituitarisme." } }, { "@type": "Question", "name": "Comment reconnaître un syndrome de Cushing ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Obésité centrale, vergetures et hypertension sont des signes du syndrome de Cushing." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles hormonaux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certains troubles." } }, { "@type": "Question", "name": "Comment éviter le stress sur l'axe hypothalamique ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de gestion du stress comme la méditation peuvent être bénéfiques." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils importants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans hormonaux réguliers peuvent aider à détecter des anomalies précocement." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il l'axe hormonal ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la régulation hormonale et la santé globale." } }, { "@type": "Question", "name": "Faut-il surveiller les antécédents familiaux ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles hormonaux peuvent augmenter le risque." } }, { "@type": "Question", "name": "Quels traitements pour l'hyperprolactinémie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les agonistes de la dopamine comme la cabergoline sont souvent prescrits." } }, { "@type": "Question", "name": "Comment traiter un déficit en hormone de croissance ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des injections d'hormone de croissance recombinante sont utilisées pour le traitement." } }, { "@type": "Question", "name": "Quelles options pour l'hypothyroïdie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La lévothyroxine est le traitement standard pour l'hypothyroïdie." } }, { "@type": "Question", "name": "Comment gérer le syndrome de Cushing ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure la chirurgie, la radiothérapie ou des médicaments." } }, { "@type": "Question", "name": "Quels médicaments pour l'hypopituitarisme ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des hormones de remplacement sont administrées selon les déficits identifiés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'hypopituitarisme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent l'insuffisance surrénalienne et des troubles métaboliques." } }, { "@type": "Question", "name": "Quels risques avec un excès de cortisol ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Un excès de cortisol peut entraîner le diabète, l'hypertension et des infections." } }, { "@type": "Question", "name": "Comment l'hyperthyroïdie affecte-t-elle le cœur ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des arythmies et une hypertension, augmentant le risque cardiaque." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'un traitement inapproprié ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement inapproprié peut aggraver les symptômes et entraîner des complications graves." } }, { "@type": "Question", "name": "Quels effets secondaires des médicaments hormonaux ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des nausées, des maux de tête et des changements d'humeur." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'hypopituitarisme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de tumeurs hypophysaires ou de radiothérapie augmentent le risque." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber l'axe hypothalamohypophysaire." } }, { "@type": "Question", "name": "L'âge influence-t-il les troubles hormonaux ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de troubles hormonaux augmente avec l'âge." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent affecter l'axe hormonal." } }, { "@type": "Question", "name": "Y a-t-il un lien avec l'obésité ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité peut perturber la régulation hormonale et augmenter le risque de troubles." } } ] } ] }

Sources (10000 au total)

Insulin promotes the proliferation and migration of pancreatic cancer cells by up-regulating the expression of PLK1 through the PI3K/AKT pathway.

Pancreatic cancer has a particularly poor prognosis compared to other tumors. The peculiar hyperinsulin microenvironment of the pancreas is formed due to the endocrine secretion of islets in the pancr...

Proliferation, Metastasis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells in the Expression and Effect of Kiwifruit Extract through the Regulation of miR-205-5p.

Radix Actinidiae extract (RAE) has been shown to inhibit cancer in many studies, but its potential mechanism in nasopharyngeal cancer (NPC) progression remains unclear.... NPC cells (SUNE1) were treated with different doses of RAE. For transfection, SUNE1 cells were transfected with the microRNA (miR)-205-5p inhibitor (anti-miR-205-5p) or mimic followed by treatment wit... RAE inhibited NPC cell proliferation, migration, and invasion, while it enhanced radiosensitivity (... RAE might decrease miR-205-5p, thereby it inhibited NPC cell proliferation and metastasis and enhanced radiosensitivity....

Potential donor-dependent regulative effects of endogenous sclerostin expression and mineralization potential in primary human PDL cells in vitro.

The glycoprotein sclerostin is mostly expressed in osteocytes and plays a central role in human bone metabolism. However, sclerostin and the corresponding SOST gene have been found in periodontal liga... Primary human periodontal ligament cells of three different donors were cultivated under control or mineralizing conditions for 6, 13, 15 and 18 days, respectively. Calcium deposits were stained with ... Alizarin red staining identified calcium deposits in periodontal ligament cells under mineralizing conditions beginning from day 13, relative SOST expression occurred on day 6. Whereas staining contin... Our data emphasize donor-specific characteristics in differentiation potential and sclerostin expression patterns in primary human periodontal ligament cells. Sclerostin might play a central role in m...

Pseudomonas response regulators produced in an E. coli heterologous expression host exhibit host-derived post-translational phosphorylation.

In this report, we systematically characterize 32 response regulators (RRs) from a metal tolerant groundwater isolate, Pseudomonas stutzeri RCH2 to assess the impact of host-derived post-translational...